News | Mammography | March 24, 2017

GE Healthcare Launches Senographe Pristina Mammography System

System is purposefully designed to help reduce pain, discomfort and anxiety for patients to improve the mammography experience

GE Healthcare, Senographe Pristina mammography system, launch, RSNA 2017, patient comfort

March 24, 2017 — GE Healthcare announced the launch of its new Senographe Pristina mammography system, designed to make breast screening more comfortable and inviting for patients.

A recent study conducted by Evans, et.al, found that painful exams explain why 25 to 46 percent1 of women failed to return for further breast imaging. The study concluded that effective pain-reducing interventions in mammography are needed to encourage more women to come in for screening. The target participation rate in Canadian organized breast cancer screening programs is 70 per cent of eligible women2. Currently all provincial programs fall below this rate2.

Senographe Pristina features a range of ergonomic features that are intentionally designed to enable patients to be more comfortable. All parts in contact with the patient's breasts, for example, have gentle, rounded corners for greater comfort. The system features comfortable armrests that relax the pectoral muscles to simplify positioning, compression and image acquisition.

Traditional mammography systems compress the breast automatically, which can be a source of considerable discomfort. Senographe Pristina features a self-compression tool that helps give women a sense of control by allowing them to manually adjust the degree of breast compression. Under the direction of a technologist, the patient can set compression to a level that feels right for them.

Taken together, these design features mean that technologists are better able to focus on precise positioning, making exams easier and faster. Poor positioning is the cause of most clinical image deficiencies that often require a rescan3.

For more information: www.gehealthcare.com

References

1. Whelehan P, Evans A, Wells M, Macgillivray S. The effect of mammography pain on repeat participation in breast cancer screening: a systematic review. Breast. 2013; 22(4):389–94.

2. Cancer Screening in Canada: An Overview of Screening Participation for Breast, Cervical and Colorectal Cancer, http://www.partnershipagainstcancer.ca

3. U.S. Food and Drug Administration http://www.fda.gov/Radiation-EmittingProducts/MammographyQualityStandardsActandProgram/FacilityScorecard/ucm495378.htm

Related Content

Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast

Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast. A small mass with micro-calcifications on the right-side breast was detected correctly by AI with an abnormality score of 96%. This case was recalled by 7 out of 14 radiologists (4 breast radiologists and 3 general radiologists) initially (without AI) and all 14 radiologists recalled this case correctly with the assistance of AI.

News | Artificial Intelligence | February 11, 2020
February 11, 2020 — A new study, published in...
Sponsored Content | Videos | Artificial Intelligence | February 06, 2020
ProFound AI is an FDA-cleared artificial intelligence (AI) system for reading 3-D breast tomosynthesis images.
Feature | Breast Imaging | February 03, 2020 | By Barbara Smith
Women in the United States have a 1 in 8 (or about 13 percent) lifetime risk of being diagnosed with breast cancer du
ringing the cancer bell can do more harm than good, says an ASTRO study

Image courtesy of ASTRO

News | Radiation Oncology | January 27, 2020
January 27, 2020 — It's a scene that some cancer patients dream about: they celebrate the end of a course of radiatio
A 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast

A 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast. (A) Unenhanced fat-saturated T1-weighted MRI shows extreme amount of FGT (ACR d). (B) Moderate BPE is seen on dynamic contrast-enhanced MRI at 90 s. (C) Mean ADC of breast parenchyma of contralateral breast on diffusion-weighted imaging with ADC mapping is 1.5 × 10?3 mm2/s. (D) On 18F-FDG PET/CT, lesion is not 18F-FDG-avid, and BPU of normal breast parenchyma is relatively high, with SUVmax of 3.2. Photo courtesy of K Pinker, et al., Medical University of Vienna, Vienna, Austria

News | PET-MRI | January 27, 2020
January 27, 2020 — Researchers have identified several potentially useful...
Sponsored Content | Videos | Mammography | January 24, 2020
Imaging Technology News Contributing Editor Greg Freiherr interviewed...
Virtual reality during chemotherapy has been shown to improve breast cancer patients’ quality of life during the most stressful treatments
News | Virtual and Augmented Reality | January 21, 2020
January 21, 2020 — Virtual reality during chemotherapy has been shown to improve...
This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.   #RSNA #

This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.

Feature | RSNA | January 20, 2020 | Dave Fornell, Editor
Here are images of some of the newest new medical imaging technologies displayed on the expo floor at the ...
The study found that DBN laws helped some women understand they had increased breast density, but not that breast density is associated with a higher risk of breast cancer or that dense breasts limit the ability of mammograms to detect cancer
News | Breast Density | January 09, 2020
January 9, 2020 — A new study suggests that state-mandated notifications on...